If you need more lookups,
subscriptions start at $34 USD/month.
Jack Scannell Location
Edinburgh, GB
Jack Scannell Work
2025 -now Venture Director @
2021 -now Founder and CEO @ Etheros Pharmaceuticals
2014 -now Founder and MD @ JW Scannell Analytics LTD
2016 -2019 Co-head of Pharmaceuticals - Equity Research @
2013 -2014 Head of Discovery Research @
2005 -2012 Head of European Healthcare @
2000 -2005 Management consultant @
1995 -1999 University Lecturer @ Neural Systems Group, Newcastle University
1991 -1995 Researcher in Computational Neuroscience and Systems Neuroscience @ University of Oxford, Department of Physiology
Jack Scannell Education
Oxford University
Doctor of Philosophy (Philosophy, Neuroscience)
1991-1995
Trinity College, Cambridge University
(Zoology)
1986-1989
Jack Scannell Skills
Molecular Biology
Equity Research
Financial Modeling
Network Pharmacology
Lifesciences
Data Analysis
Due Diligence
Biotechnology
Valuation
Computational Neuroscience
Bioinformatics
Systems Biology
Life Sciences
R&D
Equities
Drug Discovery
Jack Scannell Summary
Jack Scannell, based in Edinburgh, GB, is currently a Venture Director at Hiro Capital. Jack Scannell brings experience from previous roles at Etheros Pharmaceuticals, JW Scannell Analytics LTD, UBS and e-Therapeutics PLC. Jack Scannell holds a 1991 - 1995 Doctor of Philosophy in Philosophy, Neuroscience @ Oxford University. With a robust skill set that includes Molecular Biology, Equity Research, Financial Modeling, Network Pharmacology, Lifesciences and more. Jack Scannell has 1 emails on RocketReach.
Looking for a different Jack Scannell?
Find contact details for 700 million professionals.